The Medical Purity Analyzer Market, estimated at USD 451.1 Mn in 2025, is expected to exhibit a CAGR of 5.8% and reach USD 669.4 Mn by 2032.
The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.
The key market players are focused on adopting growth strategies, such as partnerships and acquisitions, and increasing technological advancements by market players which will drive the global medical purity analyzer market growth during the forecast period. For instance, in August 2025, International Gas Detectors (IGD), a manufacturing company that sells control panels, gas detection products, spare parts, and accessories has announced a new partnership with SG Safety AS, a supplier of safety equipment. This partnership further extends IGD’s global distributor and partner network. This union enables IGD and SG Safety AS to promote and provide access to IGD’s addressable gas detection technology.
Global Medical Purity Analyzer Market– Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2025 as "coronavirus disease 2025" or COVID-19. This virus spreads quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries such as India, China, Brazil, and others, faced problems with regard to the transportation of drugs from one place to another.
COVID-19 had a positive impact on the global medical purity analyzer market owing to the increasing demand for medical oxygen and governments were scaling up their existing facilities to fill the oxygen demand. For instance, in September 2025, according to an article published in Environmental Science and Pollution Research Journal, during the COVID-19 pandemic, long-term oxygen therapy is required at both hospitals and in-home settings that the respiratory physician should supervise for optimal treatment, which increases the demand for medical oxygen.
Global Medical Purity Analyzer Market: Key Developments
In December 2025, Yokogawa Electric Corporation, a Japan-based multinational electrical engineering and software company, announced that it developed ZR802S explosion-proof converter. ZR802S converter supports the IECEx, FM, ATEX, CSA, China Ex, Korea Ex, India Ex, and Taiwan Ex explosion-proof standards. It is intended for use with the ZR22S explosion-proof zirconia oxygen detector, an existing Yokogawa product with a highly durable zirconia sensor that is highly dust resistant and easy to install and replace. Together, ZR802S converter and ZR22S detector comprise a complete oxygen analyzer system.
On January 5, 2025, QED ENVIRONMENTAL SYSTEMS, a provider of environmental technology solutions, announced the launch of Landtec Biogas 3000 fixed gas analyzer. The device is a next-generation system offering continuous monitoring of the complete gas production process.